Cardinal Health Management
Management criteria checks 0/4
Cardinal Health's CEO is Jason Hollar, appointed in Sep 2022, has a tenure of 1.83 years. total yearly compensation is $18.78M, comprised of 6.6% salary and 93.4% bonuses, including company stock and options. directly owns 0.018% of the company’s shares, worth $4.36M. The average tenure of the management team and the board of directors is 1.9 years and 2.9 years respectively.
Key information
Jason Hollar
Chief executive officer
US$18.8m
Total compensation
| CEO salary percentage | 6.6% |
| CEO tenure | 1.8yrs |
| CEO ownership | 0.02% |
| Management average tenure | 1.9yrs |
| Board average tenure | 2.9yrs |
Recent management updates
Recent updates
Cardinal Health: Growing Into The Valuation
Jul 02Cardinal Health (NYSE:CAH) Has Announced That It Will Be Increasing Its Dividend To $0.5056
Jun 11
Cardinal Health's Valuation Makes The Name Unattractive
May 26Cardinal Health Q3 Earnings: Undervalued On Strong Guidance
May 03Potential Upside For Cardinal Health, Inc. (NYSE:CAH) Not Without Risk
Apr 14Is Cardinal Health, Inc. (NYSE:CAH) Trading At A 50% Discount?
Mar 09Cardinal Health: Continued Business Growth And Huge Medical Supplies Market Penetration
Feb 20Cardinal Health, Inc. (NYSE:CAH) Just Released Its Second-Quarter Earnings: Here's What Analysts Think
Feb 03Investors Aren't Entirely Convinced By Cardinal Health, Inc.'s (NYSE:CAH) Revenues
Dec 28Cardinal Health Is Setting Up For A Great 2024
Dec 21Cardinal Health, Inc. (NYSE:CAH) Shares Could Be 45% Below Their Intrinsic Value Estimate
Nov 03Cardinal Health: A Revenue Growth Gem Plagued By Symptoms Of Negative Equity
Oct 13Cardinal Health: Better EPS Growth Clarity, Buying Back Shares, A Buy On Valuation
Aug 07Cardinal Health (NYSE:CAH) Shareholders Will Want The ROCE Trajectory To Continue
Aug 05An Intrinsic Calculation For Cardinal Health, Inc. (NYSE:CAH) Suggests It's 45% Undervalued
Jul 14Cardinal Health: Not A Long-Term Investment
May 24The Return Trends At Cardinal Health (NYSE:CAH) Look Promising
Apr 17Cardinal Health, Inc.'s (NYSE:CAH) Intrinsic Value Is Potentially 78% Above Its Share Price
Mar 30Cardinal Health: Downgrading Due To Absence Of Safety Margin (Rating Downgrade)
Feb 21Cardinal Health (NYSE:CAH) Is Due To Pay A Dividend Of $0.4957
Feb 16Cardinal Health declares $0.4957 dividend
Feb 10Cardinal Health FQ2 2023 Earnings Preview
Feb 01Cardinal Health partners with Palantir for data-driven supply chain support
Jan 26Cardinal Health Is A Tempting Healthcare Income Play
Dec 28Cardinal Health (NYSE:CAH) Will Pay A Dividend Of $0.4957
Dec 20Aaron Alt is the new finance chief at Cardinal health
Dec 19Is There An Opportunity With Cardinal Health, Inc.'s (NYSE:CAH) 44% Undervaluation?
Dec 14Cardinal Health (NYSE:CAH) Is Paying Out A Dividend Of $0.4957
Nov 16Cardinal Health: Investable In Potential Pullback Despite Weak Medical Segment
Nov 14Cardinal Health rises on Q1 earnings beat
Nov 04Cardinal Health Is Being Undervalued, Has Significant Upside In The Near Term
Oct 10Cardinal Health (NYSE:CAH) Is Paying Out A Dividend Of $0.4957
Sep 29Cardinal Health: Aristocrat Heading For A Makeover
Sep 26PayrHealth to collaborate with Cardinal Health
Sep 15Cardinal Health in pact with activist investor Elliot for value creation measures
Sep 06Cardinal Health's (NYSE:CAH) Dividend Will Be $0.4957
Sep 01Activist interest in Cardinal Health could unlock value, improve margins - Morgan Stanley
Aug 16Is It Too Late To Consider Buying Cardinal Health, Inc. (NYSE:CAH)?
Aug 15CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | US$552m |
| Dec 31 2023 | n/a | n/a | US$639m |
| Sep 30 2023 | n/a | n/a | US$156m |
| Jun 30 2023 | US$19m | US$1m | US$261m |
| Mar 31 2023 | n/a | n/a | US$463m |
| Dec 31 2022 | n/a | n/a | -US$1b |
| Sep 30 2022 | n/a | n/a | -US$1b |
| Jun 30 2022 | US$4m | US$729k | -US$933m |
| Mar 31 2022 | n/a | n/a | -US$955m |
| Dec 31 2021 | n/a | n/a | US$555m |
| Sep 30 2021 | n/a | n/a | US$1b |
| Jun 30 2021 | US$4m | US$700k | US$611m |
| Mar 31 2021 | n/a | n/a | US$1b |
| Dec 31 2020 | n/a | n/a | US$1b |
| Sep 30 2020 | n/a | n/a | US$973m |
| Jun 30 2020 | US$4m | US$124k | -US$4b |
Compensation vs Market: Jason's total compensation ($USD18.78M) is above average for companies of similar size in the US market ($USD13.38M).
Compensation vs Earnings: Jason's compensation has increased by more than 20% in the past year.
CEO
Jason Hollar (51 yo)
1.8yrs
Tenure
US$18,776,433
Compensation
Mr. Jason M. Hollar has been Chief Executive Officer of Cardinal Health, Inc. since September 01, 2022. He serves as Director at Cardinal Health, Inc. from August 11, 2022 and had been Chief Financial Offi...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 1.8yrs | US$18.78m | 0.018% $ 4.4m | |
| Chief Financial Officer | 1.4yrs | US$6.00m | 0.00095% $ 224.2k | |
| Chief Legal & Compliance Officer | 5.3yrs | US$4.40m | 0.016% $ 3.7m | |
| Chief Executive Officer of Medical Segment | 4.9yrs | US$4.42m | 0.0023% $ 538.2k | |
| Chief Executive Officer of Pharmaceutical & Specialty Solutions Segment | 1.8yrs | US$4.07m | 0.014% $ 3.3m | |
| Senior Vice President | 1.4yrs | US$1.26m | 0.0020% $ 479.2k | |
| Senior VP & Chief Accounting Officer | 1.8yrs | no data | 0.0043% $ 1.0m | |
| Executive VP | 1.9yrs | no data | 0.0080% $ 1.9m | |
| Vice President of Investor Relations | no data | no data | no data | |
| Chief Human Resources Officer | 5.8yrs | no data | 0.010% $ 2.4m | |
| Executive Vice President of Biopharma Solutions & Strategic Sourcing | no data | no data | no data | |
| President of Global Products & Supply Chain | 3.3yrs | no data | no data |
1.9yrs
Average Tenure
52.5yo
Average Age
Experienced Management: CAH's management team is not considered experienced ( 1.9 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 1.9yrs | US$18.78m | 0.018% $ 4.4m | |
| Independent Non-Executive Chairman | 16.9yrs | US$553.58k | 0% $ 0 | |
| Independent Director | 1.8yrs | US$310.03k | 0% $ 0 | |
| Independent Director | 10.8yrs | US$320.03k | 0.0045% $ 1.1m | |
| Independent Director | 4yrs | US$302.03k | 0% $ 0 | |
| Independent Director | 3.8yrs | US$319.95k | 0.0017% $ 394.2k | |
| Independent Director | 8.8yrs | US$300.03k | 0% $ 0 | |
| Independent Director | 6.4yrs | US$325.03k | 0% $ 0 | |
| Independent Director | 1.8yrs | US$310.03k | 0% $ 0 | |
| Independent Director | 1.8yrs | US$310.03k | 0.00019% $ 44.8k | |
| Independent Director | less than a year | no data | no data | |
| Independent Director | 1.8yrs | US$310.03k | 0.00023% $ 54.3k |
2.9yrs
Average Tenure
61yo
Average Age
Experienced Board: CAH's board of directors are not considered experienced ( 2.9 years average tenure), which suggests a new board.